Lipoprotein(a) Elevation

Lipoprotein(a) Elevation is a pathological biomarker characterized by increased circulating levels of lipoprotein(a), a lipoprotein particle composed of apolipoprotein B-100 and the glycoprotein apolipoprotein(a), which is distinguished by its strong association with premature atherosclerotic cardiovascular disease independent of other lipid abnormalities.

2.4K

Publications

145.7K

Citations

12.3K

Authors

2.2K

Institutions

Publications per year

2017–2026

355

Variants

Elevated Lipoprotein(a)High Lipoprotein(a)

Authors

12.3K

  1. ST
    Sotirios Tsimikas

    University of California San Diego, United States

    44 publications · 8.3K citations

    39

    h-index

  2. SM
    Santica M. Marcovina

    University of Washington, United States

    48 publications · 4.4K citations

    33

    h-index

  3. FK
    Florian Kronenberg

    Innsbruck Medical University, Austria

    40 publications · 5.5K citations

    31

    h-index

  4. GU
    Gerd Utermann

    Innsbruck Medical University, Austria

    37 publications · 4.8K citations

    30

    h-index

  5. BG
    Børge G. Nordestgaard

    Copenhagen University Hospital, Denmark

    32 publications · 8.8K citations

    29

    h-index

1–5 of 12.3K

Venues

  1. Atherosclerosis

    275 publications · 15.5K citations

    61

    h-index

  2. Journal of the American College of Cardiology

    JACC · 45 publications · 7.6K citations

    39

    h-index

  3. Circulation

    47 publications · 8.6K citations

    38

    h-index

  4. Journal of Lipid Research

    JLR · 56 publications · 3.9K citations

    38

    h-index

  5. Metabolism

    78 publications · 4.7K citations

    37

    h-index

1–5